Non Invasive Prenatal Testing
Opportunities in the Global NIPT market:
- The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5%.
- Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
- In the US, around 10% of babies were born to first-time mothers aged 35 and over, in 2016. Also, the median age of first-time mothers in the country increased from 24.9 years in 2000 to 26.3 years in 2014 (Source: CDC).
- According to Eurostat, in 2017, around 45% of women in the European Union who gave birth to their first child belonged to the average age group of 29.1 years. Also, in the same year, around 78,275 births of first children were reported in women aged more than 40 years.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.